Demystifying the role of tumor HPV status in recurrent and/or metastatic squamous cell carcinoma of the head and neck

Ann Oncol. 2014 Apr;25(4):760-762. doi: 10.1093/annonc/mdu095. Epub 2014 Feb 25.

Authors

A Spreafico¹, E Amir¹, L L Siu²

Affiliations

¹ Division of Medical Oncology and Hematology Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
² Division of Medical Oncology and Hematology Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. Electronic address: [email protected].

PMID: 24569917
DOI: 10.1093/annonc/mdu095

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal, Humanized / administration & dosage*
Carcinoma, Squamous Cell / drug therapy*
Cetuximab
Cyclin-Dependent Kinase Inhibitor p16 / isolation & purification*
Female
Head and Neck Neoplasms / drug therapy*
Humans
Male
Neoplasm Recurrence, Local / drug therapy*

Substances

Antibodies, Monoclonal, Humanized
Cyclin-Dependent Kinase Inhibitor p16
Cetuximab